These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22194934)

  • 1. Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B.
    Jiang X; Zhang M; Lai Q; Huang X; Li Y; Sun J; Abbott WG; Ma S; Hou J
    PLoS One; 2011; 6(12):e28871. PubMed ID: 22194934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antiviral therapy with Telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients.
    Shi TD; Zhang JM; Wang XF; Chen M; Sun H; Chen CB; Ren H
    Clin Exp Med; 2012 Jun; 12(2):105-13. PubMed ID: 21748522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y; Li X; Ye B; Yang X; Wu W; Chen B; Pan X; Cao H; Li L
    Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.
    Lai Q; Ma S; Ge J; Huang Z; Huang X; Jiang X; Li Y; Zhang M; Zhang X; Sun J; Abbott WG; Hou J
    PLoS One; 2014; 9(2):e88475. PubMed ID: 24551107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection.
    Li M; Zhou ZH; Sun XH; Zhang X; Zhu XJ; Jin SG; Jiang Y; Gao YT; Li CZ; Gao YQ
    Hepatol Int; 2016 Jul; 10(4):594-601. PubMed ID: 26924524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L; Cai YJ; Yu L; Feng JY; Wang J; Li C; Niu JQ; Jiang YF
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment.
    Diao H; He J; Zheng Q; Chen J; Cui G; Wei Y; Ye P; Kohanawa M; Li L
    Immunol Lett; 2014 Jul; 160(1):65-71. PubMed ID: 24718278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of telbivudine on peripheral blood CD4+CD25+ regulatory T cells and its significance in patients with chronic hepatitis B].
    Pan XC; Yang F; Chen M
    Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):885-8. PubMed ID: 19105929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.
    Li C; Ji H; Cai Y; Ayana DA; Lv P; Liu M; Jiang Y
    J Interferon Cytokine Res; 2013 Oct; 33(10):612-8. PubMed ID: 23697556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Hepatic CD1d Levels Coincide with Invariant NKT Cell Defects in Chronic Hepatitis B Virus Infection.
    Tan X; Ding Y; Zhu P; Dou R; Liang Z; Yang D; Huang Z; Wang W; Wu X; Weng X
    J Immunol; 2018 May; 200(10):3530-3538. PubMed ID: 29643189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B.
    Nan XP; Zhang Y; Yu HT; Sun RL; Peng MJ; Li Y; Su WJ; Lian JQ; Wang JP; Bai XF
    Viral Immunol; 2012 Feb; 25(1):21-8. PubMed ID: 22233255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B.
    Ma SW; Huang X; Li YY; Tang LB; Sun XF; Jiang XT; Zhang YX; Sun J; Liu ZH; Abbott WG; Dong YH; Naoumov NV; Hou JL
    J Hepatol; 2012 Apr; 56(4):775-81. PubMed ID: 22173154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels.
    Lv GC; Ma WJ; Ying LJ; Jin X; Zheng L; Yang YD
    World J Gastroenterol; 2010 Aug; 16(32):4095-9. PubMed ID: 20731026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B].
    Xie DY; Lin BL; Chen FJ; Deng H; Chong YT; Zhang XH; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):646-50. PubMed ID: 20943073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic analysis of CD127 expression on memory CD8 T cells from patients with chronic hepatitis B during telbivudine treatment.
    Lv G; Ying L; Ma WJ; Jin X; Zheng L; Li L; Yang Y
    Virol J; 2010 Aug; 7():207. PubMed ID: 20807412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telbivudine: a review of its use in compensated chronic hepatitis B.
    McKeage K; Keam SJ
    Drugs; 2010 Oct; 70(14):1857-83. PubMed ID: 20836578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA.
    Yan Z; Zhou J; Zhang M; Fu X; Wu Y; Wang Y
    Mol Med Rep; 2014 May; 9(5):2024-30. PubMed ID: 24626572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome.
    Seto WK; Lai CL; Fung J; Wong DK; Yuen JC; Hung IF; Yuen MF
    J Hepatol; 2011 Sep; 55(3):522-528. PubMed ID: 21147187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study.
    Yang X; Li J; Liu J; Gao M; Zhou L; Lu W
    Medicine (Baltimore); 2017 Jun; 96(23):e7064. PubMed ID: 28591041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telbivudine therapy may shape CD4(+) T-cell response to prevent liver fibrosis in patients with chronic hepatitis B.
    Li J; Jia M; Liu Y; She W; Li L; Wang J; Jiang W
    Liver Int; 2015 Mar; 35(3):834-45. PubMed ID: 24814578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.